Expression of cyclin A, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin

Optimized anti-tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule

(2011) H. Ehrhardt et al.   BLOOD

Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model

(2011) Min Wei et al.   CANCER SCIENCE

Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras

(2011) Sergio Acin et al.   JOURNAL OF PATHOLOGY

Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines

(2011) Katrin Tiemann et al.   LEUKEMIA & LYMPHOMA

The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status

(2009) Valentina Turinetto et al.   BMC CANCER

Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins

(2009) Anna Litwiniec et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cyclin-Dependent Kinase 1-Mediated Bcl-xL/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis

(2009) D. T. Terrano et al.   MOLECULAR AND CELLULAR BIOLOGY

Knocking-Down Cyclin A2 by siRNA Suppresses Apoptosis and Switches Differentiation Pathways in K562 Cells upon Administration with Doxorubicin

(2009) Xiaohui Wang et al.   PLoS One

Speeding through cell cycle roadblocks: Nuclear cyclin D1-dependent kinase and neoplastic transformation

(2008) Laura L Pontano et al.   Cell Division